Latest Breaking News On - Jeremym levin - Page 1 : vimarsana.com

HC Wainwright Reaffirms Buy Rating for Ovid Therapeutics (NASDAQ:OVID)

HC Wainwright reaffirmed their buy rating on shares of Ovid Therapeutics (NASDAQ:OVID – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. HC Wainwright currently has a $9.00 target price on the stock. Other analysts also recently issued reports about the stock. Wedbush began coverage on shares of Ovid Therapeutics […]

United statesJeremym levinSg americas securitiesJump financialOvid therapeutics company profileOvid therapeutics incSecurities exchange commissionChina universal asset management coWealth managementOvid therapeuticsFree reportModerate buyGet free reportExchange commissionUniversal asset managementTherapeutics inc

Brokerages Set Ovid Therapeutics Inc (NASDAQ:OVID) PT at $8 08

Brokerages Set Ovid Therapeutics Inc (NASDAQ:OVID) PT at $8 08
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJeremym levinOvid therapeutics company profileJump financialOvid therapeutics incSg americas securitiesSecurities exchange commissionWealth managementOvid therapeuticsGet free reportExchange commissionPoint capitalGet freeTherapeutics incOvid therapeutics daily

Brokerages Set Ovid Therapeutics Inc (NASDAQ:OVID) Target Price at $8 08

Brokerages Set Ovid Therapeutics Inc (NASDAQ:OVID) Target Price at $8 08
defenseworld.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from defenseworld.net Daily Mail and Mail on Sunday newspapers.

United statesJeremym levinConnor clark lunn investment management ltdChina universal asset management coSg americas securitiesOvid therapeutics incJump financialOvid therapeuticsGet free reportLunn investment managementChina universal asset managementGet freeTherapeutics incOvid therapeutics daily

Ovid Therapeutics (NASDAQ:OVID) Price Target Lowered to $3 50 at Citigroup

Ovid Therapeutics (NASDAQ:OVID) Price Target Lowered to $3 50 at Citigroup
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJeremym levinConnor clark lunn investment management ltdOvid therapeutics incWealth managementOvid therapeuticsGet free reportTherapeutics stock downPoint capitalConnor clarkLunn investment managementTherapeutics incOvid therapeutics daily

Ovid Therapeutics (NASDAQ:OVID) PT Lowered to $3 50 at Citigroup

Ovid Therapeutics (NASDAQ:OVID) PT Lowered to $3 50 at Citigroup
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJeremym levinConnor clark lunn investment management ltdJump financialOvid therapeutics company profileChina universal asset management coSg americas securitiesOvid therapeutics incOvid therapeuticsGet free reportTherapeutics trading downLunn investment managementChina universal asset managementTherapeutics incOvid therapeutics daily